Ob-Gyn Lags in Placing Women in Department Leadership

Share this content:
Ob-Gyn Lags in Placing Women in Department Leadership
Ob-Gyn Lags in Placing Women in Department Leadership

TUESDAY, Feb. 23, 2016 (HealthDay News) -- Compared with other clinical specialties, obstetrics and gynecology is behind in progressing women to departmental leadership, according to research published in the March issue of Obstetrics & Gynecology.

Lisa G. Hofler, M.D., M.P.H., of Harvard Medical School in Boston, and colleagues conducted a cross-sectional observational study to examine the representation of women in department-based leadership for obstetrics and gynecology versus other clinical specialties. The gender of department-based leaders and residency program directors was researched on websites for 950 U.S. academic clinical departments.

The researchers found that women were significantly underrepresented as chairs (ratios, 0.60 or less; P ≤ 0.02) for all specialties and as division directors for all specialties except anesthesiology (ratio, 1.13) and diagnostic radiology (ratio, 0.97). In obstetrics and gynecology, anesthesiology, general surgery, and pediatrics, women were significantly overrepresented as residency program directors (ratios greater than 1.19; P ≤ 0.046).

"Despite having the largest proportion of leaders who were women, representation ratios demonstrate obstetrics and gynecology is behind other specialties in progression of women to departmental leadership," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »